LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
18,898,994
Share change
+2,034,171
Total reported value
$79,373,762
Put/Call ratio
92%
Price per share
$4.20
Number of holders
69
Value change
+$8,959,956
Number of buys
30
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q1 2020

As of 31 Mar 2020, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,898,994 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 69 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.